© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Accuray Incorporated (ARAY) stock surged +1.79%, trading at $2.28 on NASDAQ, up from the previous close of $2.24. The stock opened at $2.22, fluctuating between $2.18 and $2.32 in the recent session.
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Employees | 987 |
Beta | 1.4 |
Sales or Revenue | $446.55M |
5Y Sales Change% | -0.011% |
Fiscal Year Ends | June |
Sector | Healthcare |
Industry | Medical - Specialties |
Accuray Incorporated (NASDAQ: ARAY) stock price is $2.28 in the last trading session. During the trading session, ARAY stock reached the peak price of $2.32 while $2.18 was the lowest point it dropped to. The percentage change in ARAY stock occurred in the recent session was 1.79% while the dollar amount for the price change in ARAY stock was $0.04.
The NASDAQ listed ARAY is part of Medical - Specialties industry that operates in the broader Healthcare sector. Accuray Incorporated designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Beth Kaplan
PR Director
Mr. Joshua H. Levine
Consultant
Mr. Michael Hoge
Senior Vice President of Global Operations
Ms. Suzanne Winter M.B.A.
Pres, Chief Executive Officer & Director
Mr. Ali Pervaiz
Senior Vice President & Chief Financial Officer
Dr. Jean-Philippe Pignol
Senior Vice President, Chief Medical & Technology Officer
Mr. Franco N. Palomba
Vice President & Chief Accounting Officer
Mr. Jesse Chew
Senior Vice President & Chief Legal Officer
Mr. Juki Hozumi
Pres & GM of Japan Region
Ms. Melanie Gebauer
Vice President of Global HR
Mr. Patrick R. Spine
Senior Vice President & Chief Admin. Officer
Ms. Gina Corradetti
Vice President, Chief Accounting Officer, Principal Accounting Officer & Controller
Mr. GS Jha
Global Chief Information Officer & Chief Information Security Officer
ARAY's closing price is 62.86% higher than its 52-week low of $1.40 where as its distance from 52-week high of $2.95 is -22.71%.
Number of ARAY employees currently stands at 987.
Official Website of ARAY is: https://www.accuray.com
ARAY could be contacted at phone 608 824 2800 and can also be accessed through its website. ARAY operates from 1240 Deming Way, Madison, WI 53717-1954, United States.
ARAY stock volume for the day was 545.97K shares. The average number of ARAY shares traded daily for last 3 months was 667.09K.
The market value of ARAY currently stands at $229.29M with its latest stock price at $2.28 and 100.57M of its shares outstanding.